Clinical Validation of a Novel Software Tool to Guide the Intravenous-to-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases

被引：0
|
作者：
Hoffert, Yannick [1 ]
Wang, Zhigang [1 ]
Fumery, Mathurin [2 ,3 ]
Nachury, Maria [4 ]
Bazoge, Maeva [5 ]
Buisson, Anthony [5 ]
Dreesen, Erwin [1 ]
机构：
[1] Katholieke Univ Leuven, Leuven, Vlaams Brabant, Belgium
[2] Picardie Jules Verne Univ, CHU Amiens, Amiens, Picardie, France
[3] Picardie Jules Verne Univ, Peritox, Amiens, Picardie, France
[4] Lille Univ & Hosp, Lille, Nord Pas De Cal, France
[5] Univ Clermont Auvergne, CHU Clemront Ferrand, Clermont Ferrand, Auvergne, France
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001034524.01104.8d
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1289
引用
收藏
页码：S921 / S922
页数：2
相关论文
共 50 条
  • [41] EVOLUTION OF CLINICAL AND PHARMACOLOGICAL PARAMETERS AFTER SWITCHING FROM INTRA-VENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE : THE REMSWITCH STUDY
    Buisson, Anthony
    Nachury, Maria
    Reymond, Maud
    Yzet, Clara
    Wils, Pauline
    Payen, Laure
    Manlay, Luc
    Pereira, Bruno
    Fumery, Mathurin
    GASTROENTEROLOGY, 2022, 162 (07) : S182 - S183
  • [42] Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH study
    Buisson, A.
    Nachury, M.
    Reymond, M.
    Yzet, C.
    Wils, P.
    Payen, L.
    Manlay, L.
    Pereira, B.
    Fumery, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I393 - I394
  • [43] COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE SHOWED NO DIFFERENCES IN IMMUNOGENICITY OR TREATMENT PERSISTENCE AT ONE YEAR
    Morda, F.
    Hancox, S.
    Black, C. J.
    Selinger, C.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S239 - S239
  • [44] Transition from intravenous to subcutaneous infliximab and vedolizumab: adherence, satisfaction and safety profile in a cohort of patients with Inflammatory Bowel Disease
    Todeschini, A.
    Geccherle, A.
    Signoretto, P.
    Fasoli, E.
    Variola, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 551 - 552
  • [45] Comparison of subcutaneous and intravenous infliximab in patients with inflammatory bowel disease showed no differences in immunogenicity or treatment persistence at one year
    Hancox, S.
    Morda, F.
    Black, C.
    Selinger, C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1836 - I1836
  • [46] Comparison of subcutaneous and intravenous infliximab in patients with inflammatory bowel disease showed no differences in immunogenicity or treatment persistence at 1 year
    Hancox, Sarah
    Morda, Francesco
    Black, Christopher J.
    Selinger, Christian Philipp
    FRONTLINE GASTROENTEROLOGY, 2025, 16 (01) : 11 - 19
  • [47] Low Rates of Transition From Subcutaneous to Intravenous Formulation in Patients With Inflammatory Bowel Diseases Treated With Vedolizumab
    Russ, Kirk B.
    Agboton, Christian
    Lindner, Dirk
    Wojtowicz, Abigail M.
    Afzali, Anita
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S815 - S816
  • [48] Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
    Bergqvist, Viktoria
    Holmgren, Johanna
    Klintman, Daniel
    Marsal, Jan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (11) : 1389 - 1401
  • [49] Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT study
    Buisson, A.
    Nachury, M.
    Bazoge, M.
    Yzet, C.
    Wils, P.
    Dodel, M.
    Coban, D.
    Pereira, B.
    Fumery, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (04) : 526 - 534
  • [50] Switching to a infliximab biosimilar: short-term results of clinical monitoring in patients with inflammatory bowel disease
    Binkhorst, Lisette
    Sobels, Annemieke
    Stuyt, Rogier
    Westerman, Elsbeth M.
    West, Rachel L.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (07) : 699 - 703
12345